发明名称 Heteroarylalkanoic acids as integrin receptor antagonists
摘要 The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively antagonizing the alphaVbeta3 and/or the alphaVbeta5 integrin without significantly antagonizing the IIb/IIIa or alphaVbeta6 integrin.
申请公布号 US2002133023(A1) 申请公布日期 2002.09.19
申请号 US20010881913 申请日期 2001.06.15
申请人 NAGARAJAN SRINIVASAN RAJ;KHANNA ISH KUMAR;TOLLEFSON MICHAEL B.;MOHLER SCOTT B.;CHEN BARBARA;RUSSELL MARK;DEVADAS BALEKUDRU;PENNING THOMAS D.;SCHRETZMAN LORI A.;SPANGLER DALE P.;BOYS MARK LAURENCE;CHANDRAKUMAR NIZAL SAMUEL;LU HUNG-FUN 发明人 NAGARAJAN SRINIVASAN RAJ;KHANNA ISH KUMAR;TOLLEFSON MICHAEL B.;MOHLER SCOTT B.;CHEN BARBARA;RUSSELL MARK;DEVADAS BALEKUDRU;PENNING THOMAS D.;SCHRETZMAN LORI A.;SPANGLER DALE P.;BOYS MARK LAURENCE;CHANDRAKUMAR NIZAL SAMUEL;LU HUNG-FUN
分类号 A61K31/4245;A61K31/4375;A61K31/4439;A61K31/444;A61K31/4545;A61K31/4709;A61K31/496;A61K31/5383;A61P3/14;A61P9/00;A61P9/08;A61P9/10;A61P19/02;A61P19/10;A61P21/00;A61P27/02;A61P35/00;A61P43/00;C07D213/74;C07D231/38;C07D233/60;C07D233/88;C07D405/12;C07D413/06;C07D413/12;C07D413/14;C07D417/12;C07D471/04;C07D498/04;(IPC1-7):C07D263/34 主分类号 A61K31/4245
代理机构 代理人
主权项
地址